GLP-1 receptor agonists stimulate insulin secretion from pancreatic beta cells in a glucose-dependent mannermeaning they only promote insulin release when blood glucose levels are elevated, which significantly reduces the risk of hypoglycaemia compared with some other diabetes medicines
While multiple treatments are available, very few directly address the central INSR/IRS pathway
Your body undergoes metabolic adaptation as it loses weight, meaning your resting energy expenditure decreases by roughly 1015% for every 10 pounds lost
Mounjaro and Period Spotting: Causes, Advice and Management Mounjaro (tirzepatide) is a dual GIP/GLP-1 receptor agonist licensed in the UK for type 2 diabetes and weight management
Enhanced erythrocyte apoptosis in sickle cell anemia, thalassemia and glucose-6-phosphate dehydrogenase deficiency
Naomi Placella, we understand the complexities of weight management and the desire to find safe and effective solutions